Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03475667
Other study ID # 2018-27-DM-EXP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 11, 2018
Est. completion date January 10, 2020

Study information

Verified date February 2023
Source Sanjay Gandhi Postgraduate Institute of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Inaccurate monitoring of mean arterial pressure (MAP) could lead to improper treatment in the form of excessive fluid infusion or unnecessary vasopressor therapy; therefore, accurate hemodynamic monitoring is crucial in treatment of septic shock. In critically ill septic patients treated with vasoactive drugs, many studies reported that radial arterial pressure monitoring significantly underestimates central arterial pressure. Insertion of a femoral line allowed a substantial reduction of the infusion rate of vasoactive drugs in these patients. These findings might imply that femoral placement of arterial lines is the gold standard for invasive arterial blood pressure monitoring in shock patient. Our study aimed to determine the difference between radial (peripheral) and femoral (central) arterial pressures measured simultaneously in a group of critically ill patients receiving high dose noradrenaline therapy (≥ 0.1 mcg/kg/min).


Description:

Invasive arterial blood pressure monitoring is common in critically ill patients admitted in intensive care units (ICUs). The most common indication for invasive arterial blood pressure monitoring is for continuous measurement in hemodynamically unstable patients on vasopressor therapies Invasive arterial blood pressure monitoring is a standard of care during shock management in the ICU. The Surviving Sepsis Campaign international consensus guidelines (2016) recommend maintaining a mean arterial pressure (MAP) of 65 mmHg or greater, as a goal of initial resuscitation, and to apply vasopressors, if required, to maintain MAP at this level. The radial artery is most commonly used, with the femoral artery being the second choice; both site accounting as 92% of all arterial cannulations. Accuracy of invasive blood pressure monitoring is crucial in evaluating the cardiocirculatory system and adjusting vasopressor therapy for hemodynamic support. However, the best site for catheter insertion is controversial. Compared with arterial pressure waveforms measured in the central arteries (eg, aorta or femoral artery), those at the periphery (eg, radial artery) characteristically have steeper upstrokes, higher systolic peaks, a later appearing diastolic notch, more prominent diastolic waves and lower end-diastolic pressure. Yet, under normal physiological conditions, only a negligible decrement in MAP occurs. In critically ill patients during aberrant hemodynamic conditions like septic shock, gradients in MAP may develop from the central to the peripheral arterial site. There are some available studies where simultaneous measurement of radial and femoral was done in different patient population. In all studies where patients of cardiopulmonary bypass were included showed that there was significant difference in MAP and SBP between femoral and radial invasive blood pressure measurements with femoral site IBP being greater than radial site. Similar difference in SBP and MAP was noted in reperfusion stage of liver transplant patients. The difference was also found in septic shock patients in MAP with vasopressor usage but one study did not find significant difference in invasive MAP and SBP. Work plan methodology: This is a prospective observational study to know the difference in blood pressure recordings of invasive arterial BP (radial versus femoral site) in patients of septic shock on high dose of noradrenaline therapy (≥0.1 mcg/kg/min) for at least 30 minutes. Participant will be included from ICU of department of critical care medicine. All adult critically ill patients with septic shock requiring noradrenaline infusion (≥0.1 mcg/kg/min) will be considered for inclusion in this study. Participant will be included if treating team considered to change the site of arterial invasive blood pressure monitoring from radial to femoral site (same side, left or right). All three measurements: systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean blood pressure (MAP) will be recorded three times, simultaneously on the monitor within 5 minutes of placement of femoral arterial catheter by freezing/taking snapshot of the monitor. Measurement will be recorded in supine position, with radial arterial line transducer at the level of 5th rib in mid-axillary line. Femoral line transducer will be placed at the same level as radial line transducer; the equality of the levels of both the transducers will be confirmed with the help of spirit level technique. Investigators will use 20 gauge arterial cannula for radial artery cannulation and 16 gauge single lumen catheters for femoral artery cannulation with all aseptic precautions. Participant with any change in noradrenaline dose requirement during study period (measurement of pressures) will be excluded from the analysis Sample size and statistical analysis: From the previous observational study considering minimum average difference of mean MAP of 2.8 mm of Hg, investigators calculated the sample size with power analysis by using version 2008 (PASS-8). A sample size of 44 achieves 90% power to detect a mean of paired differences of 2.8 with an estimated standard deviation of differences of 5.6 and with a significance level (alpha) of 0.05 using a two-sided paired t-test. In this study, investigators would also like to do the subgroup analysis in patients on very high dose of noradrenaline (≥0.3 mcg/kg/min). So, investigators will include 80 patients. Mean of three recordings each of SBP, DBP and MBP will be calculated and appropriate statistical methods will be applied Intervention: None Duration of the study: 21 months


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date January 10, 2020
Est. primary completion date January 10, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All ICU patients who are =18 years with septic shock on high dose of noradrenaline (=0.1 mcg/kg/min) for at least 30 minutes Exclusion Criteria: - Age <18 years - Pregnancy - Patient who cannot be made supine as per clinical condition - Patients having abdominal compartment syndrome - Known peripheral vascular disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
India Department of Critical Care Medicine, SGPGIMS Lucknow UP

Sponsors (1)

Lead Sponsor Collaborator
Sanjay Gandhi Postgraduate Institute of Medical Sciences

Country where clinical trial is conducted

India, 

References & Publications (1)

Bhaskar B, Gurjar M, Mishra P, Azim A, Poddar B, Baronia AK. Arterial site selection for measurement of mean arterial pressure in septic shock patients on high-dose norepinephrine. Front Med (Lausanne). 2022 Dec 23;9:1019752. doi: 10.3389/fmed.2022.101975 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To compare radial and femoral arterial invasive blood pressure measurements in patients receiving high dose of noradrenaline (= 0.1 mcg/kg/min). Comparison of radial and femoral artery site invasive blood pressure measurement in septic patients on high dose of noradrenaline Within 5 minutes of placement of femoral artery catheter
See also
  Status Clinical Trial Phase
Recruiting NCT03649633 - Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock Phase 1/Phase 2
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Completed NCT05629780 - Temporal Changes of Lactate in CLASSIC Patients N/A
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT05066256 - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02676427 - Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
Recruiting NCT02580240 - Administration of Hydrocortisone for the Treatment of Septic Shock N/A
Terminated NCT02335723 - ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber N/A
Not yet recruiting NCT02547467 - TOADS Study: TO Assess Death From Septic Shock. N/A
Completed NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock Phase 3
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4
Completed NCT02306928 - PK Analysis of Piperacillin in Septic Shock Patients N/A